Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 309507, 7 pages
http://dx.doi.org/10.1155/2014/309507
Research Article

Systemic Oxidative Stress and Conversion to Dementia of Elderly Patients with Mild Cognitive Impairment

1Section of Medical Biochemistry, Molecular Biology and Genetics, Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, Via Borsari 46, 44121 Ferrara, Italy
2Gerontology and Geriatric Research Laboratory, IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Viale Cappuccini 1, 71013 Foggia, Italy
3Section of Internal Medicine, Gerontology, and Clinical Nutrition, Department of Medical Science, University of Ferrara, Via Savonarola 9, 44100 Ferrara, Italy
4Department of Life Sciences and Biotechnology, University of Ferrara, Via Borsari 46, 44121 Ferrara, Italy
5Department of Food and Nutrition, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea
6Geriatrics Unit, Azienda ULSS 16 Padova, S. Antonio Hospital, Via Facciolati 71, 35127 Padova, Italy

Received 13 November 2013; Accepted 13 December 2013; Published 12 January 2014

Academic Editor: Cristina Angeloni

Copyright © 2014 Carlo Cervellati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. R. Markesbery, F. A. Schmitt, R. J. Kryscio, D. G. Davis, C. D. Smith, and D. R. Wekstein, “Neuropathologic substrate of mild cognitive impairment,” Archives of Neurology, vol. 63, no. 1, pp. 38–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. C. Petersen, R. Doody, A. Kurz et al., “Current concepts in mild cognitive impairment,” Archives of Neurology, vol. 58, no. 12, pp. 1985–1992, 2001. View at Google Scholar · View at Scopus
  3. D. Anchisi, B. Borroni, M. Franceschi et al., “Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease,” Archives of Neurology, vol. 62, no. 11, pp. 1728–1733, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Lovell and W. R. Markesbery, “Oxidative damage in mild cognitive impairment and early Alzheimer's disease,” Journal of Neuroscience Research, vol. 85, no. 14, pp. 3036–3040, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Rinaldi, M. C. Polidori, A. Metastasio et al., “Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease,” Neurobiology of Aging, vol. 24, no. 7, pp. 915–919, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Valacchi, C. Sticozzi, A. Pecorelli et al., “Cutaneous responses to environmental stressors,” Annals of the New York Academy of Science, vol. 1271, pp. 75–81, 2012. View at Google Scholar
  7. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, and A. Milzani, “Biomarkers of oxidative damage in human disease,” Clinical Chemistry, vol. 52, no. 4, pp. 601–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Bergamini, S. Gambetti, A. Dondi, and C. Cervellati, “Oxygen, reactive oxygen species and tissue damage,” Current Pharmaceutical Design, vol. 10, no. 14, pp. 1611–1626, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Boyd-Kimball, R. Sultana, H. F. Poon et al., “Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1–42) into rat brain: implications for Alzheimer's disease,” Neuroscience, vol. 132, no. 2, pp. 313–324, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Matsuoka, M. Picciano, J. la Francois, and K. Duff, “Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease,” Neuroscience, vol. 104, no. 3, pp. 609–613, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Praticò, K. Uryu, S. Leight, J. Q. Trojanoswki, and V. M.-Y. Lee, “Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Azheimer amyloidosis,” Journal of Neuroscience, vol. 21, no. 12, pp. 4183–4187, 2001. View at Google Scholar · View at Scopus
  12. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. J. Barnham, C. L. Masters, and A. I. Bush, “Neurodegenerative diseases and oxidatives stress,” Nature Reviews Drug Discovery, vol. 3, no. 3, pp. 205–214, 2004. View at Google Scholar · View at Scopus
  14. P. Mao and P. H. Reddy, “Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics,” Biochimica et Biophysica Acta, vol. 1812, no. 11, pp. 1359–1370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Cervellati, E. Cremonini, C. Bosi et al., “Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease,” Current Alzheimer Research, vol. 10, no. 4, pp. 365–372, 2013. View at Google Scholar
  16. M. C. Irizarry, Y. Yao, B. T. Hyman, J. H. Growdon, and D. Praticò, “Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease,” Neurodegenerative Diseases, vol. 4, no. 6, pp. 403–405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Guidi, D. Galimberti, S. Lonati et al., “Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease,” Neurobiology of Aging, vol. 27, no. 2, pp. 262–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Zuliani, M. Ranzini, G. Guerra et al., “Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia,” Journal of Psychiatric Research, vol. 41, no. 8, pp. 686–693, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. G. McKhann, D. Drachman, and M. Folstein, “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease,” Neurology, vol. 34, no. 7, pp. 939–944, 1984. View at Google Scholar · View at Scopus
  20. A. Alberti, L. Bolognini, D. Macciantelli, and M. Caratelli, “The radical cation of N,N-diethl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples,” Research on Chemical Intermediates, vol. 26, no. 3, pp. 253–267, 2000. View at Google Scholar · View at Scopus
  21. C. Cervellati, F. S. Pansini, G. Bonaccorsi et al., “17β-estradiol levels and oxidative balance in a population of pre-, peri-, and post-menopausal women,” Gynecological Endocrinology, vol. 27, no. 12, pp. 1028–1032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. I. F. F. Benzie and J. J. Strain, “Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration,” Methods in Enzymology, vol. 299, pp. 15–27, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Cremonini, G. Bonaccorsi, C. M. Bergamini et al., “Metabolic transitions at menopause: in post-menopausal women the increase in serum uric acid correlates with abdominal adiposity as assessed by DXA,” Maturitas, vol. 75, no. 1, pp. 62–66, 2013. View at Google Scholar
  24. D. Duplancic, L. Kukoc-Modun, D. Modun, and N. Radic, “Simple and rapid method for the determination of uric acid-independent antioxidant capacity,” Molecules, vol. 16, no. 8, pp. 7058–7067, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Smith, P. L. Richey Harris, L. M. Sayre, J. S. Beckman, and G. Perry, “Widespread peroxynitrite-mediated damage in Alzheimer's disease,” Journal of Neuroscience, vol. 17, no. 8, pp. 2653–2657, 1997. View at Google Scholar · View at Scopus
  26. D. Praticò, “Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows,” Annals of the New York Academy of Sciences, vol. 1147, pp. 70–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Smith, X. Zhu, M. Tabaton et al., “Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment,” Journal of Alzheimer's Disease, vol. 19, no. 1, pp. 363–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. T. J. Montine, J. F. Quinn, D. Milatovic et al., “Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease,” Annals of Neurology, vol. 52, no. 2, pp. 175–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Sinem, K. Dildar, E. Gökhan, B. Melda, Y. Orhan, and M. Filiz, “The serum protein and lipid oxidation marker levels in Alzheimer's disease and effects of cholinesterase inhibitors and antipsychotic drugs therapy,” Current Alzheimer Research, vol. 7, no. 5, pp. 463–469, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Baldeiras, I. Santana, M. T. Proença et al., “Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment,” Journal of Alzheimer's Disease, vol. 21, no. 4, pp. 1165–1177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Brys, E. Pirraglia, K. Rich et al., “Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment,” Neurobiology of Aging, vol. 30, no. 5, pp. 682–690, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D. F. Silva, I. Santana, A. R. Esteves et al., “Prodromal metabolic phenotype in MCI cybrids: implications for Alzheimer's disease,” Current Alzheimer Research, vol. 10, no. 2, pp. 180–190, 2013. View at Google Scholar
  33. E. Barone, F. di Domenico, G. Cenini et al., “Oxidative and nitrosative modifications of biliverdin reductase-a in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment,” Journal of Alzheimer's Disease, vol. 25, no. 4, pp. 623–633, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. R. von Bernhardi and J. Eugenín, “Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms,” Antioxidants and Redox Signaling, vol. 16, no. 9, pp. 974–1031, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Sultana, M. Perluigi, and D. A. Butterfield, “Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics,” Antioxidants and Redox Signaling, vol. 8, no. 11-12, pp. 2021–2037, 2006. View at Google Scholar · View at Scopus
  36. A. Tarozzi, C. Angeloni, M. Malaguti et al., “Sulforaphane as a potential protective phytochemical against neurodegenerative diseases,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 415078, 10 pages, 2013. View at Publisher · View at Google Scholar
  37. V. Bocci and G. Valacchi, “Free radicals and antioxidants: how to reestablish redox homeostasis in chronic diseases?” Current Medicinal Chemistry, vol. 20, no. 27, pp. 3397–3415, 2013. View at Google Scholar
  38. P. Bermejo, S. Martín-Aragón, J. Benedí et al., “Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease,” Immunology Letters, vol. 117, no. 2, pp. 198–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Martín-Aragón, P. Bermejo-Bescós, J. Benedí et al., “Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease,” Neurochemical Research, vol. 35, no. 2, pp. 373–378, 2008. View at Google Scholar
  40. R. C. Petersen, R. G. Thomas, M. Grundman et al., “Vitamin E and donepezil for the treatment of mild cognitive impairment,” The New England Journal of Medicine, vol. 352, no. 23, pp. 2379–2388, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Pecorelli, L. Ciccoli, C. Signorini et al., “Increased levels of 4HNE-protein plasma adducts in Rett syndrome,” Clinical Biochemistry, vol. 44, no. 5-6, pp. 368–371, 2011. View at Publisher · View at Google Scholar · View at Scopus